Greg Bosch

Greg Bosch is an accomplished executive in the pharmaceutical and biotechnology sectors, currently serving as Chairman and CEO of Panavance Therapeutics Inc. since June 2021. In addition to this role, Bosch acts as a Strategic Advisor at Autem Therapeutics and serves on the Board of Directors for Kibow Biotech and was a board member at the Osteo Science Foundation until June 2022. Previously, Bosch held the position of CEO at Geistlich Pharma North America and President & CEO at PuriCore. Greg's extensive experience also includes a Vice President role at Baxter Healthcare Corporation and various positions at American Hospital Supply. Bosch holds a BA in Public Policy from Duke University and an MBA in Finance from the University of California, Irvine, along with supplementary education from DePaul Driehaus College of Business.